Isogenica Ltd

Isogenica is a small internationally operating Biotech business that operates a range of discovery platforms supported by state of the art methodologies for identifying antibody and peptide ligands. Our platforms benefit from a combination of intelligent library design and precision library construction, to create synthetic libraries with unprecedented functional diversity.

Our platforms benefit from a combination of intelligent library design and precision library construction, to create synthetic libraries with unprecedented functional diversity. 

Isogenica was originally launched to develop and operate its proprietary cell-free, DNA-based display technology, CIS display, as a platform for the discovery of polypeptide biologics.

Following the acquisition and development of further technologies, including the Colibra™ DNA library building platform, we now offer opportunities for discovery partnerships with access to our skills and tools, including next-generation, best-in-class antibody libraries such as our camelid VHH (llamdA™), Fab fragment and human scFv (Xab™) libraries.

These libraries are available for license and screening partnerships which, together with our expertise in the screening of displayed peptide and scaffold libraries, can facilitate your biologics discovery needs.

Stay up to date with Isogenica Ltd

Login or create a free user account to follow this company and see updates on your dashboard.

Create account